Gel Mark Ultra Biopsy Site Marker - Marker, lesion localization, implantable

Država: Australija

Jezik: engleski

Izvor: Department of Health (Therapeutic Goods Administration)

Dostupno od:

Bard Australia Pty Ltd

Razred:

Class III

Proizveden od:

SenoRx Inc 1625 W 3rd Street, Tempe, AZ, 82581 United States Of America

Područje terapije:

40808 - Marker, lesion localization, implantable

Terapijske indikacije:

A disposable applicator containing resorbable polylactic acid/polyglycolic acid (PLA/PGA) pellets with an embedded stainless steel radiopaque wireform, intended for long term radiographic marking of the biospy site. Pellets are visible via ultrasound for approx. 6 weeks and resorbed in approx. 12 weeks. The pellets are deployed from the applicator through the biopsy device into the biopsy cavity. An implant used to radiographically mark breast tissue during a percutaneous breast biopsy procedure.

Status autorizacije:

A

Datum autorizacije:

2009-03-11